Renal cell carcinomaKidney transplantGraftectomyNephron-sparing surgeryFocal ablationReviewCurrently, there is no consensus among the transplant community about the treatment of renal cell carcinoma (RCC) of the transplanted kidney. Until recently, graftectomy was universally considered the golden standard, ...
If the results show that you have renal cell carcinoma, your doctor will find out what stage it’s in, so you can decide on the best treatment options. The stage of cancer depends on how large your tumor is and whether the cancer has spread to other parts of your body. You may have...
At this year's ASCO Annual Meeting, researchers presented detailed findings concerning biomarkers and rare subtypes of renal cell carcinoma. Identifying aunique biomarker can be achallenging endeavor, but patients with metastatic RCC are living longer due to the availability of multiple therapeutic ...
EP: 1.Renal Cell Carcinoma: Risk Stratification and Evolving Treatment Landscape EP: 2.Case 1: Therapeutic Sequencing for Relapsed/Refractory Metastatic Clear Cell RCC EP: 3.RCC: Treatment Goals in the Third-Line Setting EP: 4.TIVO-3: Tivozanib vs Sorafenib in Advanced Renal Cell Carcinoma EP...
Renal cell carcinoma is the 14th most common cancer worldwide. It is a heterogeneous group of histopathological entities, of which the most common is clear cell renal cell carcinoma. Approximately 20–30% of patients present initially with metastatic disease and an additional 20% will progress afte...
105 The use of these drugs has been associated with improved outcomes in non-small cell lung cancer (NSCLC), melanoma, renal cell carcinoma (RCC), and other cancers. This progress marks a significant breakthrough in cancer therapy due to the development of PD-1 and PD-L1 ICIs. Cytotoxic ...
Eric Jonasch, MD:Hi. I'm Dr Eric Jonasch. I'm a medical oncologist at MD Anderson Cancer Center. I'm joined by Dr Katy Beckermann, who's a medical oncologist at Vanderbilt. Our topic today is patients with favorable-risk advanced renal cell carcinoma. How should we treat these individu...
REVIEW British Journal of Cancer (2016) 115, 505–516 | doi: 10.1038/bjc.2016.230 Keywords: systemic therapy; metastatic renal cell carcinoma; T-cell checkpoint inhibitors; tyrosine kinase inhibitors Medical treatment of renal cancer: new horizons Basma Greef*,1 and Tim Eisen2 1Department of ...
N., TokudaH., UchinoF., MorokumaTokuda N, et al. Pre-surgical sunitinib treatment for renal cell carcinoma: A case series. Urology 84 (Suppl. 4): S173 abstr. 009, Oct 2014. Available from: URL: http://.org/10.1016/S0090-4295%2814%2901020-6 [abstract] - ...
of the literature, we underline the impact of nephrectomy combined with sequential therapy based on cytokines, antiangiogenic factors, and mammalian target of rapamycin inhibitors along with metastasectomy on overall survival and quality of life in patients with metastatic clear cell renal carcinoma. ...